Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Tandem Diabetes Care, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $1.73B | $1.69B - $1.78B | -$202.64M | $1.787 | 9 |
| Dec 2029 | $1.56B | $1.52B - $1.60B | -$182.10M | $1.445 | 11 |
| Dec 2028 | $1.36B | $1.36B - $1.37B | -$159.50M | $0.775 | 18 |
| Dec 2027 | $1.20B | $1.16B - $1.26B | -$140.81M | $0.082 | 17 |
| Dec 2026 | $1.07B | $1.05B - $1.08B | -$125.46M | -$0.678 | 16 |
| Dec 2025 | $1.00B | $997.76M - $1.01B | -$117.05M | -$2.085 | 15 |
| Dec 2024 | $908.03M | $901.52M - $933.95M | -$106.15M | -$1.689 | 13 |
| Dec 2023 | $796.00M | $778.13M - $818.67M | -$93.05M | -$2.093 | 7 |
| Dec 2022 | $802.00M | $787.32M - $814.92M | $52.32M | -$1.088 | 6 |
| Dec 2021 | $691.83M | $679.16M - $702.97M | $47.68M | $0.303 | 6 |
| Dec 2020 | $472.10M | $463.45M - $479.70M | $1.59M | -$0.716 | 11 |
| Dec 2019 | $363.13M | $356.49M - $368.99M | -$5.36M | -$0.514 | 6 |